Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ian Ford

Showing results (321-330 of 508) with videos related to

Pageof 51
Sort By:
European Journal of Heart Failure|May 20, 2025
Recurrent event analyses in patients receiving maintenance dialysis and the effect of higher- versus lower-dose chronic intravenous iron therapy: A report focusing on heart failure events from the PIVOTAL trialStefan D Anker, Michele Robertson, John J V McMurray, et al.
Behavioural Brain Research|August 25, 2012
Early life socioeconomic status, chronic physiological stress and hippocampal N-acetyl aspartate concentrationsJohn McLean, Rajeev Krishnadas, G David Batty, et al.
Journal of Cardiovascular Computed Tomography|October 10, 2022
Randomized comparison of chest pain evaluation with FFR<sub>CT</sub> or standard care: Factors determining US costsMark A Hlatky, Sam Wilding, Beth Stuart, et al.
Atherosclerosis|May 13, 2014
In search for genetic determinants of clinically meaningful differential cardiovascular event reduction by pravastatin in the PHArmacogenetic study of Statins in the Elderly at risk (PHASE)/PROSPER studyIris Postmus, Paul C D Johnson, Stella Trompet, et al.
Annals of Neurology|June 20, 2014
N-terminal pro-brain natriuretic peptide and cognitive decline in older adults at high cardiovascular riskLiselotte W Wijsman, Behnam Sabayan, Peter van Vliet, et al.
Annals of Internal Medicine|May 5, 2020
L-Thyroxine Therapy for Older Adults With Subclinical Hypothyroidism and Hypothyroid Symptoms: Secondary Analysis of a Randomized TrialMaria de Montmollin, Martin Feller, Shanthi Beglinger, et al.
Atherosclerosis|February 12, 2008
Genetic variation at the PCSK9 locus moderately lowers low-density lipoprotein cholesterol levels, but does not significantly lower vascular disease risk in an elderly populationEliana Polisecki, Inga Peter, Michele Robertson, et al.
The Lancet. Diabetes & Endocrinology|June 16, 2017
Cardiovascular and metabolic effects of metformin in patients with type 1 diabetes (REMOVAL): a double-blind, randomised, placebo-controlled trialJohn R Petrie, Nishi Chaturvedi, Ian Ford, et al.
Endocrine Reviews|February 16, 2017
Unraveling the Directional Link between Adiposity and Inflammation: A Bidirectional Mendelian Randomization ApproachPaul Welsh, Eliana Polisecki, Michele Robertson, et al.
JCI Insight|October 5, 2016
Microvascular resistance of the culprit coronary artery in acute ST-elevation myocardial infarctionDavid Carrick, Caroline Haig, Jaclyn Carberry, et al.
Pageof 51

Showing results (321-330 of 508) with videos related to

Sort By:
Pageof 51
European Journal of Heart Failure|May 20, 2025
Recurrent event analyses in patients receiving maintenance dialysis and the effect of higher- versus lower-dose chronic intravenous iron therapy: A report focusing on heart failure events from the PIVOTAL trialStefan D Anker, Michele Robertson, John J V McMurray, et al.
Behavioural Brain Research|August 25, 2012
Early life socioeconomic status, chronic physiological stress and hippocampal N-acetyl aspartate concentrationsJohn McLean, Rajeev Krishnadas, G David Batty, et al.
Journal of Cardiovascular Computed Tomography|October 10, 2022
Randomized comparison of chest pain evaluation with FFR<sub>CT</sub> or standard care: Factors determining US costsMark A Hlatky, Sam Wilding, Beth Stuart, et al.
Atherosclerosis|May 13, 2014
In search for genetic determinants of clinically meaningful differential cardiovascular event reduction by pravastatin in the PHArmacogenetic study of Statins in the Elderly at risk (PHASE)/PROSPER studyIris Postmus, Paul C D Johnson, Stella Trompet, et al.
Annals of Neurology|June 20, 2014
N-terminal pro-brain natriuretic peptide and cognitive decline in older adults at high cardiovascular riskLiselotte W Wijsman, Behnam Sabayan, Peter van Vliet, et al.
Annals of Internal Medicine|May 5, 2020
L-Thyroxine Therapy for Older Adults With Subclinical Hypothyroidism and Hypothyroid Symptoms: Secondary Analysis of a Randomized TrialMaria de Montmollin, Martin Feller, Shanthi Beglinger, et al.
Atherosclerosis|February 12, 2008
Genetic variation at the PCSK9 locus moderately lowers low-density lipoprotein cholesterol levels, but does not significantly lower vascular disease risk in an elderly populationEliana Polisecki, Inga Peter, Michele Robertson, et al.
The Lancet. Diabetes & Endocrinology|June 16, 2017
Cardiovascular and metabolic effects of metformin in patients with type 1 diabetes (REMOVAL): a double-blind, randomised, placebo-controlled trialJohn R Petrie, Nishi Chaturvedi, Ian Ford, et al.
Endocrine Reviews|February 16, 2017
Unraveling the Directional Link between Adiposity and Inflammation: A Bidirectional Mendelian Randomization ApproachPaul Welsh, Eliana Polisecki, Michele Robertson, et al.
JCI Insight|October 5, 2016
Microvascular resistance of the culprit coronary artery in acute ST-elevation myocardial infarctionDavid Carrick, Caroline Haig, Jaclyn Carberry, et al.
Pageof 51